In this article we report an investigation concerning analogues of the thrombin binding aptamer (TBA) in which thymidines have been replaced, one at a time, by the unusual residue 5-hydroxymethyl-2'-deoxyuridine (hmU) that differs from the canonical thymidine only in the presence of an hydroxyl on the 5-methyl group. NMR and CD data clearly indicate that all TBA derivatives preserve the ability to fold in the original ''chair-like'' structure. The presence of the hmU residue doesn't affect notably thermal stability of the modified aptamers compared to the parent one, except the analogue H9 for which a more marked increase of the melting temperature has been observed. Although all TBA analogues have shown decreased affinities to thrombin, derivatives H3, H7 and H9 have proven to possess improved anticoagulant activities in comparison with the parent aptamer. Our data open-up the possibility to enhance the TBA biological properties, just introducing small chemical modifications.

5-Hydroxymethyl-2′-Deoxyuridine Residues in the Thrombin Binding Aptamer: Investigating Anticoagulant Activity by Making a Tiny Chemical Modification

VIRGILIO, ANTONELLA;PETRACCONE, LUIGI;VELLECCO, VALENTINA;BUCCI, MARIAROSARIA;MAYOL, LUCIANO;VARRA, MICHELA;ESPOSITO, VERONICA;GALEONE, ALDO
2014

Abstract

In this article we report an investigation concerning analogues of the thrombin binding aptamer (TBA) in which thymidines have been replaced, one at a time, by the unusual residue 5-hydroxymethyl-2'-deoxyuridine (hmU) that differs from the canonical thymidine only in the presence of an hydroxyl on the 5-methyl group. NMR and CD data clearly indicate that all TBA derivatives preserve the ability to fold in the original ''chair-like'' structure. The presence of the hmU residue doesn't affect notably thermal stability of the modified aptamers compared to the parent one, except the analogue H9 for which a more marked increase of the melting temperature has been observed. Although all TBA analogues have shown decreased affinities to thrombin, derivatives H3, H7 and H9 have proven to possess improved anticoagulant activities in comparison with the parent aptamer. Our data open-up the possibility to enhance the TBA biological properties, just introducing small chemical modifications.
File in questo prodotto:
File Dimensione Formato  
2014 CBC hmU.pdf

solo utenti autorizzati

Descrizione: full text
Licenza: Dominio pubblico
Dimensione 671.87 kB
Formato Adobe PDF
671.87 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11588/585384
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 31
social impact